Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Global Epistaxis Market, By Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Epistaxis - A Common Clinical Condition Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive

Coherent Market Insights
Global Wilson’s Disease Treatment Market, By Treatment (Medications, others), Distribution Channel (Government, Hospitals, Medical Practitioners), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Wilson's Disease Treatment Market Wilson’s disease is a genetic disorder caused by the loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which r

Coherent Market Insights
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Drugs, Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)) - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : May 2017

Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years

Coherent Market Insights
Global Erectile Dysfunction Market, By Product (Viagra (Sildenafil citrate), Cialis (Tadalafil), Stendra/Spedra, Levitra/Staxyn, Zydena (Udenafil), Vitaros (Alprostadil Cream)), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Apr 2017

Erectile Dysfunction: A Prominent Age Related Disorder Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient

Coherent Market Insights
Global Tuberculosis Drugs Market, By Therapy Type (First Line Drugs Therapy, Second Line Drugs Therapy, Combination Drugs Therapy), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Mar 2017

Tuberculosis Drugs: Hopes Pinned on Renewed Government Investments in Emerging Economies Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Thankfully, ext

Coherent Market Insights
Global Prefilled Syringes Market, By Drug Type (Biologics, Vaccines, Insulin), Material (Glass, Plastic & Polymer), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Aug 2017

Prefilled Syringes- Insights into Novel Drug Delivery System The prefilled syringes are one of the fastest growing choices for the unit dose delivery and has emerged as one of the most convenient way of drug

Coherent Market Insights
Global Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular, Diagnostics, Big Data Analytics), Application (Oncology, CNS, Hematology, Respiratory, Immunology), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025

Published Date : Sep 2017

Precision Medicine Market – Not one-size fits all Precision medicine is an emerging field, which tailors the treatment according to the individual’s genetic makeup, lifestyle, and environment. Th

Coherent Market Insights
Global Opioids Agonist Drugs Market, By Product Type (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone), Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and Geography - Trends, Analysis and Forecast till 2024

Published Date : Mar 2017

Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth Opioids are generally prescribed for treating pain. The opioid drug class includes morphine, hydrocodone, oxycodone, heroin, codeine, morphine

Coherent Market Insights
Blood Irradiation Market, by Technique (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, and Extracorporeal Blood Irradiation), by End User (Hospitals, Blood Bank, Diagnostic Clinics, and Research Institutes), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Mar 2019

Blood irradiation is a therapy in which blood components are irradiated prior to transfusion, to prevent proliferation of certain types of T lymphocytes. These T lymphocytes inhibit the immune responses and can cause a rare graft-versus-hos

Coherent Market Insights
Divalproex Sodium Market, by Dosage Form (Capsule, Tablet, and Syrup), by Application (Epilepsy, Manic Depressive Illness, and Other), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 - 2026

To Be Published : Mar 2019

Divalproex sodium is a Food and Drug Administrator (FDA) approved anti-epileptic drug used to treat migraine headaches, manic episodes of bipolar disorders, and certain types of seizures. Divalproex sodium is known for its anticonvulsant pr

Coherent Market Insights
Thebaine Market, by Applications (Oxymorphone, Nalbuphine, Naltrexone, Naloxone, Oxycodone, Buprenorphine, and Others), by Distribution Channels (Hospitals/Clinics, Online Pharmacies, and Retail pharmacies), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026.

To Be Published : Mar 2019

Thebaine is an opioid alkaloid also called as codeine methyl enol ether. Although it is a minor constituent of opium i.e. thebaine is chemically similar to codeine and morphine, thebaine has stimulatory effects instead of depressant effects

Coherent Market Insights
Procalcitonin Antibody Market, By Antibody Type (Polyclonal Procalcitonin Antibody and Monoclonal Procalcitonin Antibody), By End User (Hospitals, Research Institutes, and Others), and By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Mar 2019

Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of

Coherent Market Insights
Hypopharyngeal Cancer Treatment Market by Drug Type (Chemotherapy (Taxol, Taxtere and Methotrexate), Targeted Therapy, by Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) - Size, Share, Outlook and Opportunity Analysis 2018 - 2026

To Be Published : Mar 2019

Hypopharyngeal cancer is the malignant tumor initiated in the cells of hypopharynx. Malignant cell of the hypopharyngeal cancer can metastasis into cervical lymph nodes, pharyngeal muscles, cranial nerves, laryn

Coherent Market Insights
Deferiprone Market, by Dosage Form (Tablets, Oral Solutions, and Capsules), by Application (Transfusional Iron Overload and NTDT Caused Iron Overload), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Mar 2019

Deferiprone is an FDA approved drug that is majorly used to treat transfusion-dependent thalassemia and a wide range of disorders. Deferiprone is a type of hydroxypyridinone iron chelator that was synthesized by Dr. Kontoghiorghes in the early mid-1980s. I

Coherent Market Insights
Apixaban Market, by Dosage Form (Capsule and Tablets), Distribution Channel (Hospitals, Clinics, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 - 2026

To Be Published : Mar 2019

Apixaban is a Food and Drug Administrator (FDA) approved anticoagulant used for the treatment of venous thromboembolic events (blood clot) that forms within a vein. Venous thromboembolic events (VTE) can occur without any prior symptoms or warning signs and can go undiagnosed and unrecognized by

Coherent Market Insights
Orlistat Market, by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Mar 2019

Orlistat is a drug designed to treat obesity. Primary function of Orlistat is to prevent absorption of fat from the diet consumed by humans. It prevents absorption of fats by acting as lipase inhibitors, which eventually reduce the calorie

Coherent Market Insights
Retroperitoneal Liposarcoma Treatment Market, By Chemotherapy Treatment (Ifosfamide, Gemcitabine, Yondelis, Combinational Therapies, and Other Chemotherapies), By Type (Liposarcoma (Well-Differentiated Liposarcoma, Dedifferentiated Liposarcoma, and Others) and Leiomyosarcoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Mar 2019

Retroperitoneal liposarcoma (RLS) is a rare, biologically heterogeneous cancer, which occurs in retroperitoneum, lining of the abdominal space that covers the abdominal organs. Retroperitoneal liposarcoma grow continuously and may not get diagnosed until they are very

Coherent Market Insights
Intraocular Melanoma Treatment Market, by Treatment (Targeted Therapy (Rituximab (Rituxan), Ibritumomab (Zevalin), Imatinib (Gleevec), and sorafenib (Nexavar)), Other Therapies), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Mar 2019

Intraocular (uveal) melanoma is a rare eye cancer, characterized with blurred vision or a dark spot on the iris. Various treatment options are available for intraocular melanoma, such as eye examinations. According to the National Cancer In

Coherent Market Insights
Nanostructured Drug Market, by Technology, (Nanoparticles, Nanocrystals, Nanotubes, Liposomes, Micelles, and Others), by Applications (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Mar 2019

Nanotechnology is an emerging field of science that involves atomic or molecular level manipulation of matter. A nanometer is equals to 1 billionth of a meter. Nanotechnology has various application in different fields such as chemical sens

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.